JP2023542932A5 - - Google Patents
Info
- Publication number
- JP2023542932A5 JP2023542932A5 JP2023518198A JP2023518198A JP2023542932A5 JP 2023542932 A5 JP2023542932 A5 JP 2023542932A5 JP 2023518198 A JP2023518198 A JP 2023518198A JP 2023518198 A JP2023518198 A JP 2023518198A JP 2023542932 A5 JP2023542932 A5 JP 2023542932A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- approximately
- composition according
- therapeutically effective
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063080165P | 2020-09-18 | 2020-09-18 | |
| US63/080,165 | 2020-09-18 | ||
| US202163159397P | 2021-03-10 | 2021-03-10 | |
| US63/159,397 | 2021-03-10 | ||
| PCT/US2021/050677 WO2022060987A1 (en) | 2020-09-18 | 2021-09-16 | Triphenyl calcilytic compounds for the treatment of autosomal dominant hypocalcemia type 1 (adh1) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023542932A JP2023542932A (ja) | 2023-10-12 |
| JP2023542932A5 true JP2023542932A5 (cg-RX-API-DMAC7.html) | 2024-09-25 |
Family
ID=78087574
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023518198A Pending JP2023542932A (ja) | 2020-09-18 | 2021-09-16 | 常染色体優性低カルシウム血症1型(adh1)の治療のためのトリフェニルカルシリティック化合物 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220087961A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4213829A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023542932A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230112609A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021343475A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3192684A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL301409A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023003129A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202227046A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022060987A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116648243A (zh) | 2020-08-04 | 2023-08-25 | 柯西立提克斯疗法有限公司 | 三苯基钙敏感化合物的制剂 |
| WO2024220796A1 (en) * | 2023-04-21 | 2024-10-24 | Calcilytix Therapeutics, Inc. | Treatment of hypoparathyroidism using triphenyl calcilytic compounds |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20050460A1 (es) * | 2003-04-23 | 2005-07-08 | Japan Tobacco Inc | COMPUESTOS HETEROCICLICOS COMO ANTAGONISTAS CaSR (RECEPTOR SENSIBLE AL CALCIO) |
| CN116648243A (zh) * | 2020-08-04 | 2023-08-25 | 柯西立提克斯疗法有限公司 | 三苯基钙敏感化合物的制剂 |
-
2021
- 2021-09-16 MX MX2023003129A patent/MX2023003129A/es unknown
- 2021-09-16 CA CA3192684A patent/CA3192684A1/en active Pending
- 2021-09-16 US US17/477,198 patent/US20220087961A1/en not_active Abandoned
- 2021-09-16 IL IL301409A patent/IL301409A/en unknown
- 2021-09-16 AU AU2021343475A patent/AU2021343475A1/en active Pending
- 2021-09-16 KR KR1020237012476A patent/KR20230112609A/ko active Pending
- 2021-09-16 JP JP2023518198A patent/JP2023542932A/ja active Pending
- 2021-09-16 EP EP21790717.9A patent/EP4213829A1/en active Pending
- 2021-09-16 WO PCT/US2021/050677 patent/WO2022060987A1/en not_active Ceased
- 2021-09-17 TW TW110134985A patent/TW202227046A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7199157B2 (en) | Use of treprostinil to improve kidney functions | |
| JP6023734B2 (ja) | 二次性副甲状腺機能亢進症の治療及び予防方法 | |
| EP2648737B1 (en) | Treating conditions associated with increased eotaxin with 25-hydroxyvitamin d3 | |
| JP7177534B2 (ja) | マカ組成物および使用方法 | |
| CN100531731C (zh) | 谷氨酸盐、谷氨酸盐衍生物或代谢产物、谷氨酸盐类似物或其混合物在制备治疗骨质疏松症的组合物中的用途 | |
| US8481514B2 (en) | Therapeutical uses of inecalcitol | |
| WO2008058355A2 (en) | Descriptive report of patent of invention of the medicament 'atorvastatin + metformin' in combined form for cardiovascular diseases | |
| RU2586742C2 (ru) | Композиция для лечения метаболических расстройств | |
| JP3255926B2 (ja) | 腎機能障害患者における燐酸塩過剰血症予防のための19−ノル−ビタミンd化合物の使用 | |
| US20260102370A1 (en) | Methods of treating obesity in responder and non-responder populations | |
| Brown et al. | Vitamin D analogs: new therapeutic agents for secondary hyperparathyroidism | |
| US20100331286A1 (en) | Combination therapy for treatment of bone and mineral disorders for patients with impaired renal function | |
| JP7344422B2 (ja) | 糖尿病予防・治療用の医薬品組成物及びその用途 | |
| JP2021020917A (ja) | サクビトリルおよびバルサルタンの組合せの新規使用 | |
| JP2731063B2 (ja) | 卵巣欠落によるのぼせ治療剤 | |
| US20220347141A1 (en) | Methods of treating phosphate concentration disorders with l-baiba | |
| EP2162127A1 (en) | Composition useful for the prevention of adverse effect due to the use of ppar-gamma agonists | |
| JP2026515152A (ja) | トリフェニルカルシリティック化合物を使用した副甲状腺機能低下症の治療 | |
| US10105375B2 (en) | Combination of low dose 2-methylene-19-nor-(20S)1α, 25-dihydroxyvitamin D3 and calcimimetics to treat secondary hyperparathyroidism | |
| JP2023170339A (ja) | 拡張型心筋症を処置または予防するための医薬組成物 | |
| WO2026088203A1 (en) | Synergistic composition for poor muscle health and sarcopenia | |
| WO2023081157A1 (en) | Medium chain dicarboxylic acids for the treatment and prevention of diseases and conditions | |
| Brown | Vitamin D analogs for the treatment of secondary hyperparathyroidism in chronic renal failure | |
| JP2007507479A (ja) | 脂質代謝を調節するための方法および手段 |